Clinical Trial

Identifying Diabetes and Impaired Glucose Tolerance in ICU Patients

Study acronym: DISCOVER
Completed
View on ClinicalTrials.gov →
Summary
In the Netherlands, patients admitted to the ICU are classified as having diabetes based on whether their medical records indicate glucose management medication use (Dutch National Intensive Care Evaluation (NICE) Registry). However, this approach does not identify patients with 1) undiagnosed diabetes, 2) uncontrolled diabetes, 3) patients managing their condition through lifestyle modifications, or 4) individuals with prediabetes, which is considered an early stage of diabetes. Consequently, this may lead to an underestimation of the "true" prevalence of chronic dysglycaemia among ICU patients and as a result the impact of various glycaemic states on acute outcomes remain underexplored.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-28.
Status change: Recruiting → Completed 2026-04-28
Trial Details
NCT Number NCT07261865
Lead Sponsor University Medical Center Groningen
Collaborators: Frisius Medisch Centrum
Conditions Diabetes (DM), Critical Illness
Enrollment 4,198 participants
Start Date 2024-05-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04